These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7648648)

  • 1. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?
    Yusuf S
    Circulation; 1995 Sep; 92(5):1079-82. PubMed ID: 7648648
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrections to the nifedipine meta-analysis.
    Furberg CD; Psaty BM
    Circulation; 1996 Apr; 93(7):1475-6. PubMed ID: 8641044
    [No Abstract]   [Full Text] [Related]  

  • 3. Nifedipine in ischemic heart disease.
    Kloner RA
    Circulation; 1995 Sep; 92(5):1074-8. PubMed ID: 7648647
    [No Abstract]   [Full Text] [Related]  

  • 4. Nifedipine and mortality. Grave defects in the dossier.
    Opie LH; Messerli FH
    Circulation; 1995 Sep; 92(5):1068-73. PubMed ID: 7648646
    [No Abstract]   [Full Text] [Related]  

  • 5. Nifedipine in patients with heart disease.
    Phillips RA; Krakoff LR
    Circulation; 1996 Apr; 93(7):1474-5. PubMed ID: 8641043
    [No Abstract]   [Full Text] [Related]  

  • 6. Risks and benefits of calcium antagonists.
    Lichtlen PR
    Lancet; 1995 Oct; 346(8980):962. PubMed ID: 7564741
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.
    Mehta JL; Subramanian VB
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641039
    [No Abstract]   [Full Text] [Related]  

  • 8. Nifedipine study.
    Lichtlen PR
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641040
    [No Abstract]   [Full Text] [Related]  

  • 9. Nifedipine Gastrointestinal Therapeutic System (GITS) in the treatment of coronary heart disease and hypertension.
    Kragten JA; Dunselman PH
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):643-53. PubMed ID: 17605643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.
    Tijssen JG; Hugenholtz PG
    Eur Heart J; 1996 Aug; 17(8):1152-7. PubMed ID: 8869855
    [No Abstract]   [Full Text] [Related]  

  • 12. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.
    Furberg CD; Psaty BM; Meyer JV
    Circulation; 1995 Sep; 92(5):1326-31. PubMed ID: 7648682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists--much noise about nothing?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits and safety of long-acting calcium antagonists in coronary artery disease: the Action Trial.
    Fagard RH
    J Hypertens; 2005 Mar; 23(3):489-91. PubMed ID: 15716687
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine in acute coronary syndromes: Furberg's refrain revisited.
    Rafflenbeul W
    Eur Heart J; 1996 Aug; 17(8):1147-52. PubMed ID: 8869854
    [No Abstract]   [Full Text] [Related]  

  • 17. Nimodipine in patients with heart disease.
    Roine RO
    Circulation; 1996 Apr; 93(7):1472-3; author reply 1473. PubMed ID: 8641041
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversies concerning calcium antagonists.
    Lichtlen PR
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):409-12. PubMed ID: 8924053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [24-hour protection and control: a new era of calcium antagonists. Amlodipine provides 24 hours of efficacy and safety].
    Med Clin (Barc); 1992 Feb; 98(8):suppl 2 p.. PubMed ID: 1532845
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with nifedipine retard: increasing doses as a therapeutic method].
    Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R
    Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.